FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W188311708> ?p ?o ?g. }

• W188311708 abstract "Hyaluronan and hyaluronidases have been used in several medical fields for many years and some hyaluronidases play a role in, e.g., meningitis, septicaemia, arthroses and cancer. To further investigate the function of hyaluronan and hyaluronidases in (patho)physiological processes, selective and potent hyaluronidase inhibitors are required. Originated by the lack of such compounds, the main goal of this thesis was the prediction of lead-like structures by de novo ligand design.For de novo ligand design with the programme LUDI, a homology model of S. agalactiae strain 4755 hyaluronidase (hylB4755) was constructed starting from two bacterial hyaluronidases. Screening of the LeadQuest®, Accelrys and the adapted ChemACX (ChemACXF) databases resulted in 1275 hits. 13 out of 19 selected compounds were active on hylB4755 in the milli- and submillimolar range. 1,3-Diacetylbenzimidazole-2-thione was identified to be one of the most potent inhibitors of bacterial hyaluronidases (IC50 values of 5 µM and 160 µM at physiological pH and optimum pH, respectively).To validate the usage of the aforementioned databases in virtual screening, the distribution of six (physico)chemical properties (molecular weight, log P, numbers of H-bond donors and acceptors, numbers of rotatable bonds and of rings) within these databases were analysed with respect to drug-likeness. The analysis revealed that the LeadQuest® databases Vol. 1&2 and Vol. 1-3 are suitable compound selections for virtual screening with drug-like molecules. Furthermore, the raw pre-filtering of the ChemACX database by elimination of reactive compounds and of entities outside a certain molecular weight range resulted in a database with significantly different property distributions, though covering the essential pharmacological space.For de novo design of inhibitors of bovine testicular hyaluronidase (BTH) a homology model of the enzyme based on crystal structures of bee venom hyaluronidase was constructed using MODELLER. Filtering of the Lead-Quest® and the ChemACXF databases resulted in ca. 5500 hits. 5 compounds were selected for testing hyaluronidase inhibition; none of the compounds inhibited BTH. Additionally, a ligand-based approach was performed. The superposition of the active sites of the BTH model, the crystal structures of bee venom hyaluronidase and the bacterial chitinases A and B in complex with inhibitors revealed a very good overlap of the amino acids involved in catalysis and of the co-crystallised ligands. By considering essential substructures mimicking the proposed intermediate of hyaluronic acid hydrolysis and by introducing suitable substituents suggested to interact with amino acids of the active site of the bovine enzyme, two compounds were proposed as potential inhibitors of BTH.Due to the weak inhibition of S. pneumoniae hyaluronidase by vitamin C, the more hydrophobic derivative L-ascorbic acid-6-hexadecanoate was investigated and proved to be a potent inhibitor of hylB4755, S. pneumoniae hyaluronidase and BTH (IC50 values of 4 µM, 100 µM and 56 µM, respectively). The binding mode of L-ascorbic acid-6-hexadecanoate at S. pneumoniae hyaluronidase was determined by X-ray analysis, supporting the hypothesis that additional hydrophobic interactions in the active site contribute to the higher affinity. The potential binding mode of L-ascorbic acid-6-hexadecanoate at BTH was predicted by flexible docking with FlexX suggesting two alternative binding modes. That binding mode seems to be clearly favoured where the long alkyl chain of L-ascorbic acid-6-hexadecanoate favourably interacts with an extended, strongly hydrophobic channel.The analysis of two hyaluronate lyase-inhibitor complexes revealed that the the indole moiety of the inhibitor sulfamic acid 1-decyl-2-(4-sulfamoyloxy-phenyl)-1H-indol-6-yl ester and the vitamin C portion of L-ascorbic acid-6-hexadecanoate bind in exactly the same region of the catalytic site. Additionally, the long aliphatic substituents of both compounds dunk in the same surface crevice. Using the programmes LUDI and GRID, regions where H-bond donor, H-bond acceptor and hydrophobic moieties of inhibitors may interact most favourably were identified and transferred into a 3D pharmacophore model. The analysis of known SAR of 2-phenylindole derivatives with respect to the observed binding mode of sulfamic acid 1-decyl-2-(4-sulfamoyloxy-phenyl)-1H-indol-6-yl ester and to the 3D pharmacophore model led to suggestions about the binding mode of benzoxazole-2-thione derivatives. Based on the superposition of the crystal structure of this bacterial lyase in complex with the co-crystallised indole derivative and a substrate-based hexasaccharide, novel benzoxazole-2-thiones with 3-substituted N-propanoyl groups were predicted as putative hyaluronate lyase inhibitors. This design strategy was confirmed by the activity of the 3-phenylpropanoyl derivative which potently inhibits hylB4755 with an IC50 value of 15 µM." @default.
• W188311708 created "2016-06-24" @default.
• W188311708 creator A5080832589 @default.
• W188311708 date "2004-06-13" @default.
• W188311708 modified "2023-09-27" @default.
• W188311708 title "Structure-based design of hyaluronidase inhibitors" @default.
• W188311708 cites W131380269 @default.
• W188311708 cites W1480889166 @default.
• W188311708 cites W1484101819 @default.
• W188311708 cites W1497251686 @default.
• W188311708 cites W1498217478 @default.
• W188311708 cites W1502415301 @default.
• W188311708 cites W1505394602 @default.
• W188311708 cites W1509196567 @default.
• W188311708 cites W1517566065 @default.
• W188311708 cites W1539796472 @default.
• W188311708 cites W1541597653 @default.
• W188311708 cites W1574994167 @default.
• W188311708 cites W1581588296 @default.
• W188311708 cites W1582109070 @default.
• W188311708 cites W1592238003 @default.
• W188311708 cites W1593247367 @default.
• W188311708 cites W1596348044 @default.
• W188311708 cites W1600039811 @default.
• W188311708 cites W1606992230 @default.
• W188311708 cites W1650631537 @default.
• W188311708 cites W1656114533 @default.
• W188311708 cites W1935712031 @default.
• W188311708 cites W1963723282 @default.
• W188311708 cites W1963863434 @default.
• W188311708 cites W1964958542 @default.
• W188311708 cites W1969130197 @default.
• W188311708 cites W1970617335 @default.
• W188311708 cites W1971458166 @default.
• W188311708 cites W1975964241 @default.
• W188311708 cites W1976748778 @default.
• W188311708 cites W1977467384 @default.
• W188311708 cites W1978325385 @default.
• W188311708 cites W1979205372 @default.
• W188311708 cites W1980374511 @default.
• W188311708 cites W1980949045 @default.
• W188311708 cites W1982694126 @default.
• W188311708 cites W1983790404 @default.
• W188311708 cites W1985952540 @default.
• W188311708 cites W1986191025 @default.
• W188311708 cites W1986693510 @default.
• W188311708 cites W1988424812 @default.
• W188311708 cites W1990300531 @default.
• W188311708 cites W1990472384 @default.
• W188311708 cites W1990762118 @default.
• W188311708 cites W1993165124 @default.
• W188311708 cites W1993404146 @default.
• W188311708 cites W1994859764 @default.
• W188311708 cites W1995017064 @default.
• W188311708 cites W1996932553 @default.
• W188311708 cites W1998135283 @default.
• W188311708 cites W1999329886 @default.
• W188311708 cites W2000485912 @default.
• W188311708 cites W2001641653 @default.
• W188311708 cites W2003356525 @default.
• W188311708 cites W2003937594 @default.
• W188311708 cites W200440428 @default.
• W188311708 cites W2009730930 @default.
• W188311708 cites W2010311431 @default.
• W188311708 cites W2010595835 @default.
• W188311708 cites W2012856015 @default.
• W188311708 cites W2015792715 @default.
• W188311708 cites W2018914741 @default.
• W188311708 cites W2020907391 @default.
• W188311708 cites W2022442703 @default.
• W188311708 cites W2028533348 @default.
• W188311708 cites W2030232210 @default.
• W188311708 cites W2030337803 @default.
• W188311708 cites W2030997781 @default.
• W188311708 cites W2031194866 @default.
• W188311708 cites W2033474431 @default.
• W188311708 cites W2035292911 @default.
• W188311708 cites W2035349592 @default.
• W188311708 cites W2038393352 @default.
• W188311708 cites W2040971099 @default.
• W188311708 cites W2048552934 @default.
• W188311708 cites W2048571383 @default.
• W188311708 cites W2048772145 @default.
• W188311708 cites W2049192005 @default.
• W188311708 cites W2051287611 @default.
• W188311708 cites W2051547987 @default.
• W188311708 cites W2051630780 @default.
• W188311708 cites W2054525948 @default.
• W188311708 cites W2056783190 @default.
• W188311708 cites W2057843842 @default.
• W188311708 cites W2057914895 @default.
• W188311708 cites W2059509103 @default.
• W188311708 cites W2059896404 @default.
• W188311708 cites W2061545244 @default.
• W188311708 cites W2065283382 @default.
• W188311708 cites W2065895195 @default.
• W188311708 cites W2066638035 @default.
• W188311708 cites W2068017935 @default.
• W188311708 cites W2069955268 @default.
• W188311708 cites W2071046678 @default.

• next